Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: A real-life evidence from biostar nationwide registry

Basit Öğe Kaydı
dc.authorid0000-0002-5852-3854
dc.contributor.authorDuruöz, Mehmet Tuncay
dc.contributor.authorAtaman, Şebnem
dc.contributor.authorBodur, Hafize
dc.contributor.authorÇay, H. F.
dc.contributor.authorAlkan Melikoğlu, Meltem
dc.contributor.authorAkgül, Özgür
dc.contributor.authorÇapkın, Erol
dc.contributor.authorGürer, Gülcan
dc.contributor.authorÇevik, Remzi
dc.contributor.authorGöğüş, Feride Nur
dc.contributor.authorKamanlı, Ayhan
dc.contributor.authorYurdakul, Fatma Gül
dc.contributor.authorYağcı, İlker
dc.contributor.authorRezvani, Aylin
dc.contributor.authorAltan İnceoğlu, Lale
dc.date.accessioned2024-02-26T10:44:45Z
dc.date.available2024-02-26T10:44:45Z
dc.date.issued2023
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Fizik Tedavi ve Rehabilitasyon Ana Bilim Dalı
dc.description.abstractBackground: Patients with rheumatoid arthritis (RA) have increased morbidity and mortality due to cardiovascular (CV) comorbidities. Objectives: The association of CV diseases (CVD) and traditional CV risk factors have been debated, depending on patient and RA characteristics. This study aimed to find the prevalence of CVD and CV risk factors in patients with RA. Methods: A multi-center cross-sectional study was performed on RA patients using the BioSTAR (Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs Registry). Socio-demographic, clinical, and follow-up data were collected. Patients with and without major adverse cardiovascular events (MACE) were grouped as Group 1 and Group 2. Prevalence rates of CVD and traditional CV risk factors were the primary outcomes. Secondary outcomes were the differences in the clinical characteristics between patients with and without CVD.
dc.identifier.citationDuruöz, M. T., Ataman, Ş., Bodur, H., Çay, H. F., Alkan Melikoğlu, M., Akgül, Ö. ... Altan İnceoğlu, L. (2023). Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: A real-life evidence from biostar nationwide registry. European Congress of Rheumatology (EULAR) içinde (1330-1330. ss.). Milan, Italy, 31 May-03 June, 2023. https://dx.doi.org/10.1136/annrheumdis-2023-eular.2103
dc.identifier.doi10.1136/annrheumdis-2023-eular.2103
dc.identifier.endpage1330
dc.identifier.issn0003-4967
dc.identifier.issn1468-2060
dc.identifier.issueSupplement:1
dc.identifier.startpage1330
dc.identifier.urihttps://dx.doi.org/10.1136/annrheumdis-2023-eular.2103
dc.identifier.urihttps://hdl.handle.net/20.500.12511/12314
dc.identifier.volume82
dc.identifier.wos001107398704332en_US
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.institutionauthorRezvani, Aylin
dc.language.isoen
dc.publisherBMJ Publishing Group
dc.relation.ispartofEuropean Congress of Rheumatology (EULAR)en_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectNationwide Registry
dc.subjectCardiovascular Disease
dc.subjectTraditional Cardiovascular
dc.subjectRheumatoid Arthritis
dc.titlePrevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: A real-life evidence from biostar nationwide registry
dc.typeConference Object

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Rezvani-Aylin-2023.pdf
Boyut:
218.85 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Bildiri Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu